Celgene Technician Artwork & Packaging Development (1Y temporary Contract) in Boudry, Switzerland
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
This position is responsible to ensure the definition an artwork and the necessary activities related to packaging development with the Regulatory Affairs affiliate and the Manufacturer Site (Celgene or non-Celgene) for implementing EU Serialization.
Advanced professional certificate in Graphical Industry profession (eg CFC)
ISO 15930 Standard certification
Good knowledge of the cGMP and their practical application in a pharmaceutical company
Strong skills on artwork preparation and modification, as well as packaging development processes
Good knowledge of Adobe Creative Suite and other relevant graphical design software
Good knowledge of GS1 Standards
Knowledge of the most common MS Office software
Fluent in French and English
Strong written and verbal communication
Very good team player
Duties and Responsibilities
Technical coordination and planning consolidation for EU Serialization implementation
Technical definitions of the packaging elements
Collection and Consolidation of the necessary information for EU Serialization implementation
Management of artwork preparation and/or modification for EU Serialization implementation
Relationship and support with Manufacturer Site (Celgene or non-Celgene)
Relationship and support with Regulatory Affairs affiliate (Celgene or non-Celgene)
COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE